124 related articles for article (PubMed ID: 35983753)
1. Elucidating the coordination chemistry of the radium ion for targeted alpha therapy.
Ivanov AS; Simms ME; Bryantsev VS; Benny PD; Griswold JR; Delmau LH; Thiele NA
Chem Commun (Camb); 2022 Sep; 58(71):9938-9941. PubMed ID: 35983753
[TBL] [Abstract][Full Text] [Related]
2. Reining in Radium for Nuclear Medicine: Extra-Large Chelator Development for an Extra-Large Ion.
Simms ME; Sibley MM; Driscoll DM; Kertesz V; Damron JT; Ivanov AS; White FD; Thiele NA
Inorg Chem; 2023 Dec; 62(50):20834-20843. PubMed ID: 37811965
[TBL] [Abstract][Full Text] [Related]
3. Navigating through the coordination preferences of heavy alkaline earth metals: Laying the foundations for
Franchi S; Madabeni A; Tosato M; Gentile S; Asti M; Orian L; Di Marco V
J Inorg Biochem; 2024 Jul; 256():112569. PubMed ID: 38701687
[TBL] [Abstract][Full Text] [Related]
4. Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand.
Abou DS; Thiele NA; Gutsche NT; Villmer A; Zhang H; Woods JJ; Baidoo KE; Escorcia FE; Wilson JJ; Thorek DLJ
Chem Sci; 2021 Jan; 12(10):3733-3742. PubMed ID: 34163647
[TBL] [Abstract][Full Text] [Related]
5. Advancing Chelation Strategies for Large Metal Ions for Nuclear Medicine Applications.
Hu A; Wilson JJ
Acc Chem Res; 2022 Mar; 55(6):904-915. PubMed ID: 35230803
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of potential chelating agents for radium.
Henriksen G; Hoff P; Larsen RH
Appl Radiat Isot; 2002 May; 56(5):667-71. PubMed ID: 11993940
[TBL] [Abstract][Full Text] [Related]
7. Rapid Dissolution of BaSO
Thiele NA; MacMillan SN; Wilson JJ
J Am Chem Soc; 2018 Dec; 140(49):17071-17078. PubMed ID: 30485079
[TBL] [Abstract][Full Text] [Related]
8. Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy.
Deblonde GJ; Lohrey TD; Booth CH; Carter KP; Parker BF; Larsen Å; Smeets R; Ryan OB; Cuthbertson AS; Abergel RJ
Inorg Chem; 2018 Nov; 57(22):14337-14346. PubMed ID: 30372069
[TBL] [Abstract][Full Text] [Related]
9. Chelating the Alpha Therapy Radionuclides
Hu A; Brown V; MacMillan SN; Radchenko V; Yang H; Wharton L; Ramogida CF; Wilson JJ
Inorg Chem; 2022 Jan; 61(2):801-806. PubMed ID: 34965102
[TBL] [Abstract][Full Text] [Related]
10.
Li L; Rousseau J; Jaraquemada-Peláez MG; Wang X; Robertson A; Radchenko V; Schaffer P; Lin KS; Bénard F; Orvig C
Bioconjug Chem; 2021 Jul; 32(7):1348-1363. PubMed ID: 32216377
[TBL] [Abstract][Full Text] [Related]
11. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
12. Advances in heavy alkaline earth chemistry provide insight into complexation of weakly polarizing Ra
Gilhula JC; Xu L; White FD; Adelman SL; Aldrich KE; Batista ER; Dan D; Jones ZR; Kozimor SA; Mason HE; Meyer RL; Thiele NA; Yang P; Yuan M
Sci Adv; 2024 Jan; 10(1):eadj8765. PubMed ID: 38181087
[TBL] [Abstract][Full Text] [Related]
13. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Feb; 43(2):225-233. PubMed ID: 27628177
[TBL] [Abstract][Full Text] [Related]
14. Recent Achievements about Targeted Alpha Therapy-Based Targeting Vectors and Chelating Agents.
Farzipour S; Shaghaghi Z; Abbasi S; Albooyeh H; Alvandi M
Anticancer Agents Med Chem; 2022; 22(8):1496-1510. PubMed ID: 34315393
[TBL] [Abstract][Full Text] [Related]
15. Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes.
Hu A; Aluicio-Sarduy E; Brown V; MacMillan SN; Becker KV; Barnhart TE; Radchenko V; Ramogida CF; Engle JW; Wilson JJ
J Am Chem Soc; 2021 Jul; 143(27):10429-10440. PubMed ID: 34190542
[TBL] [Abstract][Full Text] [Related]
16. Preparation of
Westrøm S; Generalov R; Bønsdorff TB; Larsen RH
Nucl Med Biol; 2017 Aug; 51():1-9. PubMed ID: 28486098
[TBL] [Abstract][Full Text] [Related]
17. Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging.
Reissig F; Bauer D; Ullrich M; Kreller M; Pietzsch J; Mamat C; Kopka K; Pietzsch HJ; Walther M
Pharmaceuticals (Basel); 2020 Sep; 13(10):. PubMed ID: 32992909
[TBL] [Abstract][Full Text] [Related]
18. A benzimidazole functionalised DO3A chelator showing pH switchable coordination modes with lanthanide ions.
Fisher CM; Fuller E; Burke BP; Mogilireddy V; Pope SJ; Sparke AE; Déchamps-Olivier I; Cadiou C; Chuburu F; Faulkner S; Archibald SJ
Dalton Trans; 2014 Jul; 43(25):9567-78. PubMed ID: 24828602
[TBL] [Abstract][Full Text] [Related]
19. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Sep; 43(9):1440-1449. PubMed ID: 28402142
[TBL] [Abstract][Full Text] [Related]
20. [
Yang Y; Alencar LMR; Pijeira MSO; Batista BDS; França ARS; Rates ERD; Lima RC; Gemini-Piperni S; Santos-Oliveira R
Drug Deliv; 2022 Dec; 29(1):186-191. PubMed ID: 35191342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
